Tablet/capsule5 mg22.7% Tablet/capsule20 mg16.8% Tablet/capsule2.5 mg9.9% Tablet/capsule15 mg5.5% Tablet/capsule7.5 mg5.5% Distribution of Days Supplied (2022) "Days supply" is defined as the number of days that a prescription should last. For example, a prescription of 60 tablets that is...
001 Zyprexa Zydis Olanzapine Tablet, Orally Disintegrating Oral 5mg Yes Yes Prescription AB 002 Zyprexa Zydis Olanzapine Tablet, Orally Disintegrating Oral 10mg Yes No Prescription AB 003 Zyprexa Zydis Olanzapine Tablet, Orally Disintegrating Oral 15mg Yes No Prescription AB 004 Zyprexa Zydis Olanzapine ...
美国上市药品目录集提供Olanzapine的基本信息,包括Olanzapine的申请号76866,申请类型,活性成分Olanzapine,中文名称奥氮平,申请机构,批准日期等药品信息,更多美国药品Olanzapine的信息查询就在戊戌数据美国上市药品数据库.
Overview:Lybalvi is an oral tablet that is used to treat schizophrenia or bipolar disorder. Common side effects include weight gain, sleepiness, dry mouth, constipation, and headache. Lybalvi can also affect your alertness or coordination. Lybalvi interacts with opioid medicines, which are used to ...
美国上市药品目录集提供Olanzapine的基本信息,包括Olanzapine的申请号202287,申请类型,活性成分Olanzapine,中文名称奥氮平,申请机构,批准日期等药品信息,更多美国药品Olanzapine的信息查询就在戊戌数据美国上市药品数据库.
ZYPREXA tablets are intended for oral administration only. Each tablet contains olanzapine equivalent to 2.5 mg (8 µmol), 5 mg (16 µmol), 7.5 mg (24 µmol), 10 mg (32 µmol), 15 mg (48 µmol), or 20 mg (64 µmol). Inactive ingredients are ...
Olanzapine is administered orally as a tablet that quickly dissolves or disintegrates in the oral cavity. Hence, it is very easy for patients, even those with emesis, to accept this medication. In addition, olanzapine is less expensive than aprepitant, which is considered to be the most effecti...
Antiemetic effects of mirtazapine are from the blockade of 5-HT3 receptors. Mirtazapine has anxiolytic effects and benefit for sleep. It is available only as an oral tablet or oral disintegrating tablet, and it is not approved for use in pediatric patients. Mirtazapine does not affect gastric ...
美国上市药品目录集提供Olanzapine的基本信息,包括Olanzapine的申请号203708,申请类型,活性成分Olanzapine,中文名称奥氮平,申请机构,批准日期等药品信息,更多美国药品Olanzapine的信息查询就在戊戌数据美国上市药品数据库.
美国上市药品目录集提供Olanzapine的基本信息,包括Olanzapine的申请号202862,申请类型,活性成分Olanzapine,中文名称奥氮平,申请机构,批准日期等药品信息,更多美国药品Olanzapine的信息查询就在戊戌数据美国上市药品数据库.